胰腺导管腺癌CT、MR相关研究进展  

Progress in CT and MR related studies of pancreatic ductal adenocarcinoma

作　　者：王天佐 姜慧杰[1] Wang Tianzuo;Jiang Huijie(CT Room,the Second Affiliated Hospital of Harbin Medical University,Heilongjiang Harbin 150000,China.)

机构地区：[1]哈尔滨医科大学附属第二医院CT室

出　　处：《现代肿瘤医学》2020年第4期672-676,共5页Journal of Modern Oncology

基　　金：国家自然科学基金面上项目(编号:81671760,81873910)

摘　　要：胰腺导管腺癌(pancreatic ductal adenocarcinoma,PDAC)是最常见的胰腺恶性肿瘤,其恶性程度高,患者生存率低。CT、MR是PDAC诊断最常用的影像检查,其不仅可以帮助PDAC进行诊断、鉴别,还能通过特殊序列来提供相应功能参数。此外,影像组学可以挖掘更多的影像信息供临床医生分析、预测患者术后生存率。CT、MR对于PDAC临床治疗具有重要的指导意义,故本文对PDAC相关CT、MR进展进行综述。Pancreatic ductal adenocarcinoma(PDAC)is the most common pancreatic cancer,which has a high malignancy and poor survival rate.CT and MR are the most commonly used imaging examination methods for PDAC diagnosis,which can not only help PDAC in diagnosis and differentiation,but also provide corresponding functional parameters through special sequences.In addition,radiomics can mine more image information for clinicians to analyze and predict postoperative survival rate.CT and MR have important guiding significance for the clinical treatment of PDAC,so this paper reviews the progress of CT and MR related to PDAC.

关 键 词：胰腺导管腺癌 CT MR 

分 类 号：R735.9[医药卫生—肿瘤]